Skip to main content

Table 1 HER2 positive incidence

From: Cost effectiveness and affordability of trastuzumab in sub-Saharan Africa for early stage HER2-positive breast cancer

Country Incidence Sources
Congo Not found  
Ethiopia 23% [31]
Guinea Not found  
Kenya 26% [33]
Namibia Not found  
Nigeria 26% [34]
Rwanda 26.3% [35]
Uganda 22% [36]
Zambia Not found  
Zimbabwe Not found  
South Africa 22.50% [37]